---
import ScienceLayout from '../../layouts/ScienceLayout.astro';
import ResearchTeam from '../../components/ResearchTeam.astro';
import { Image } from 'astro:assets';

import gaszekFig1 from '../../assets/images/science/gaszek-2025-fig1.jpg';
import gaszekFig2 from '../../assets/images/science/gaszek-2025-fig2.jpg';
import lyonFig1 from '../../assets/images/science/lyon-2025-fig1.jpg';
import lyonFig3 from '../../assets/images/science/lyon-2025-fig3.jpg';
---

<ScienceLayout title="Antibiotic Resistance Evolution | Toprak Lab" description="Understanding how bacteria evolve resistance through protein epistasis, large-scale mutagenesis, and evolutionary dynamics.">
  <section class="section">
    <div class="container">
      <p class="vision-intro">
        A central challenge in combating antibiotic resistance is understanding how bacteria evolve under drug pressure. The Toprak Lab investigates this through protein epistasis, large-scale mutagenesis, and direct observation of evolutionary dynamics — revealing rules that govern resistance emergence and inform strategies to prevent it.
      </p>
    </div>
  </section>

  <section class="section section--alt">
    <div class="container">
      <h2 class="subsection-heading">Deep Mutational Scanning</h2>
      <p class="subsection-desc">
        Systematic mapping of how single and combinatorial mutations reshape the fitness landscape of resistance enzymes.
      </p>

      <figure class="paper-figure">
        <Image src={gaszekFig1} alt="TEM-1 combinatorial mutant library design and fitness landscape under ampicillin and aztreonam selection" width={720} quality={95} densities={[1, 2]} />
        <figcaption>
          <strong>Combinatorial fitness landscape.</strong> A library of 55,296 TEM-1 &beta;-lactamase variants is systematically assayed under ampicillin and aztreonam selection, mapping how combinations of five key mutations reshape enzyme fitness across drug environments.
        </figcaption>
      </figure>
      <figure class="paper-figure">
        <Image src={gaszekFig2} alt="Graph-theoretic fitness landscape showing neutral merging and fitness peaks" width={720} quality={95} densities={[1, 2]} />
        <figcaption>
          <strong>Evolutionary unpredictability.</strong> Graph-based visualization of the fitness landscape reveals multiple accessible peaks under aztreonam — higher-order epistasis creates branching evolutionary paths that make resistance outcomes fundamentally hard to predict.
        </figcaption>
      </figure>

      <div class="article-card">
        <span class="article-card__label">Preprint 2025</span>
        <h3 class="article-card__title">Higher-order epistasis drives evolutionary unpredictability toward novel antibiotic resistance</h3>
        <p class="article-card__authors">I.K. Gaszek, M.S. Yıldız, Z. Meng, J.A. de la Paz, S.M. Alvarez, F. Morcos, M.M. Lin, E. Toprak</p>
        <p class="article-card__journal"><em>bioRxiv</em> (2025)</p>
        <p class="article-card__summary">
          Comprehensive deep mutational scanning of <strong>55,296 TEM-1 &beta;-lactamase variants</strong> yielding over <strong>8 million fitness measurements</strong>. Reveals that higher-order epistasis — interactions among three or more mutations — drives unpredictable evolutionary trajectories toward novel resistance phenotypes.
        </p>
        <div class="article-card__actions">
          <a href="https://www.biorxiv.org/content/10.1101/2025.07.08.663783v1.abstract" target="_blank" rel="noopener noreferrer" class="article-card__btn">View on bioRxiv</a>
        </div>
      </div>
    </div>
  </section>

  <section class="section">
    <div class="container">
      <h2 class="subsection-heading">Sequential Treatment Dynamics</h2>
      <p class="subsection-desc">
        How evolutionary history under one antibiotic shapes adaptation to subsequent treatments.
      </p>

      <figure class="paper-figure">
        <Image src={lyonFig1} alt="Evolution protocol scheme and survival outcomes during single antibiotic treatment" width={720} quality={95} densities={[1, 2]} />
        <figcaption>
          <strong>Sequential treatment protocol.</strong> Bacterial populations are evolved under amikacin, levofloxacin, and cefepime in isolation, establishing baseline resistance dynamics and survival outcomes for each drug.
        </figcaption>
      </figure>
      <figure class="paper-figure">
        <Image src={lyonFig3} alt="Survival and phenotypic outcomes of sequential antibiotic treatment" width={720} quality={95} densities={[1, 2]} />
        <figcaption>
          <strong>Context-dependent resistance.</strong> When antibiotics are applied in sequence, the evolutionary history under the first drug fundamentally reshapes adaptation to the second — identical drugs produce different resistance phenotypes depending on treatment order.
        </figcaption>
      </figure>

      <div class="article-card">
        <span class="article-card__label">Preprint 2025</span>
        <h3 class="article-card__title">Context-dependent evolutionary dynamics toward bacterial survival during sequential antibiotic treatment</h3>
        <p class="article-card__authors">A. Lyon, M.S. Yıldız, E. Toprak</p>
        <p class="article-card__journal"><em>bioRxiv</em> (2025)</p>
        <p class="article-card__summary">
          Demonstrates that evolutionary outcomes during sequential antibiotic treatment are context-dependent — the order and history of drug exposure fundamentally alters the trajectory of resistance evolution, with implications for clinical treatment sequencing.
        </p>
        <div class="article-card__actions">
          <a href="https://www.biorxiv.org/content/10.1101/2025.04.08.647880v2.abstract" target="_blank" rel="noopener noreferrer" class="article-card__btn">View on bioRxiv</a>
        </div>
      </div>

      <ResearchTeam area="antibiotic-resistance" />
    </div>
  </section>

  <section class="section section--alt">
    <div class="container">
      <h2 class="subsection-heading">Related Publications</h2>
      <ul class="related-list">
        <li class="related-item">
          <a href="https://www.nature.com/articles/s41467-021-23191-z" target="_blank" rel="noopener noreferrer">
            <span class="related-item__title">A trimethoprim derivative impedes antibiotic resistance evolution</span>
            <span class="related-item__meta">Manna, Tamer, Gaszek et al. &mdash; <em>Nature Communications</em>, 2021</span>
          </a>
        </li>
        <li class="related-item">
          <a href="https://academic.oup.com/mbe/article/38/10/4493/6310175" target="_blank" rel="noopener noreferrer">
            <span class="related-item__title">The antibiotic efflux protein TolC is a highly evolvable target under colicin E1 and TLS phage selection</span>
            <span class="related-item__meta">Tamer, Gaszek, Rodrigues et al. &mdash; <em>MBE</em>, 2021</span>
          </a>
        </li>
        <li class="related-item">
          <a href="https://academic.oup.com/mbe/article/36/7/1533/5458069" target="_blank" rel="noopener noreferrer">
            <span class="related-item__title">High-order epistasis in catalytic power of dihydrofolate reductase gives rise to a rugged fitness landscape in the presence of trimethoprim selection</span>
            <span class="related-item__meta">Tamer, Gaszek, Abdizadeh et al. &mdash; <em>MBE</em>, 2019</span>
          </a>
        </li>
        <li class="related-item">
          <a href="https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002552" target="_blank" rel="noopener noreferrer">
            <span class="related-item__title">Sequence-specific targeting of bacterial resistance genes increases antibiotic efficacy</span>
            <span class="related-item__meta">Ayhan, Tamer, Akbar et al. &mdash; <em>PLOS Biology</em>, 2016</span>
          </a>
        </li>
        <li class="related-item">
          <a href="https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002299" target="_blank" rel="noopener noreferrer">
            <span class="related-item__title">Quantifying the determinants of evolutionary dynamics leading to drug resistance</span>
            <span class="related-item__meta">Chevereau, Dravecka, Batur et al. &mdash; <em>PLOS Biology</em>, 2015</span>
          </a>
        </li>
        <li class="related-item">
          <a href="https://www.nature.com/articles/ncomms8385" target="_blank" rel="noopener noreferrer">
            <span class="related-item__title">Delayed commitment to evolutionary fate in antibiotic resistance fitness landscapes</span>
            <span class="related-item__meta">Palmer*, Toprak*, Baym et al. &mdash; <em>Nature Communications</em>, 2015</span>
          </a>
        </li>
        <li class="related-item">
          <a href="https://academic.oup.com/mbe/article/31/9/2387/2925782" target="_blank" rel="noopener noreferrer">
            <span class="related-item__title">Strength of selection pressure is an important parameter contributing to the complexity of antibiotic resistance evolution</span>
            <span class="related-item__meta">Oz, Guvenek, de Yozgat et al. &mdash; <em>MBE</em>, 2014</span>
          </a>
        </li>
        <li class="related-item">
          <a href="https://www.nature.com/articles/ng.1034" target="_blank" rel="noopener noreferrer">
            <span class="related-item__title">Evolutionary paths to antibiotic resistance under dynamically sustained drug selection</span>
            <span class="related-item__meta">Toprak, Veres, Michel et al. &mdash; <em>Nature Genetics</em>, 2012</span>
          </a>
        </li>
      </ul>
    </div>
  </section>
</ScienceLayout>

<style>
  .section {
    padding-block: 1.25rem;
  }

  .vision-intro {
    max-width: 720px;
    margin-inline: auto;
    font-size: var(--size-md);
    line-height: 1.7;
  }

  .subsection-heading {
    font-family: var(--font-heading);
    font-size: var(--size-xl);
    font-weight: 400;
    text-transform: none;
    letter-spacing: normal;
    color: var(--color-gray-900);
    margin-bottom: 0.5rem;
    max-width: 720px;
    margin-inline: auto;
  }

  .subsection-desc {
    font-size: var(--size-sm);
    color: var(--color-gray-600);
    line-height: 1.6;
    max-width: 720px;
    margin-inline: auto;
    margin-bottom: 0.75rem;
  }

  .paper-figure {
    max-width: 720px;
    margin-inline: auto;
    border: 1px solid var(--color-gray-100);
    border-radius: 4px;
    overflow: hidden;
    margin-bottom: 1rem;
    background: var(--color-white);
  }

  .paper-figure:last-of-type {
    margin-bottom: 1.5rem;
  }

  .paper-figure img {
    width: 100%;
    height: auto;
    display: block;
  }

  .paper-figure figcaption {
    padding: 0.625rem 1rem;
    font-size: var(--size-xs);
    color: var(--color-gray-600);
    line-height: 1.5;
    border-top: 1px solid var(--color-gray-100);
    background: var(--color-white);
  }

  .paper-figure figcaption strong {
    color: var(--color-gray-900);
  }

  .article-card {
    max-width: 720px;
    margin-inline: auto;
    border: 1px solid var(--color-gray-100);
    border-radius: 4px;
    padding: 1.75rem 2rem;
    background-color: var(--color-white);
  }

  .article-card__label {
    display: inline-block;
    font-family: var(--font-heading);
    font-size: var(--size-xs);
    font-weight: 600;
    text-transform: uppercase;
    letter-spacing: 0.08em;
    color: var(--color-navy-light);
    margin-bottom: 0.75rem;
  }

  .article-card__title {
    font-family: var(--font-heading);
    font-size: var(--size-lg);
    font-weight: 400;
    line-height: 1.4;
    margin-bottom: 1rem;
    color: var(--color-gray-900);
    text-transform: none;
    letter-spacing: normal;
  }

  .article-card__authors {
    font-size: var(--size-sm);
    color: var(--color-gray-600);
    margin-bottom: 0.25rem;
  }

  .article-card__journal {
    font-size: var(--size-sm);
    color: var(--color-gray-600);
    margin-bottom: 1rem;
  }

  .article-card__summary {
    font-size: var(--size-sm);
    line-height: 1.7;
    color: var(--color-gray-600);
    margin-bottom: 1.5rem;
    padding-top: 1rem;
    border-top: 1px solid var(--color-gray-100);
  }

  .article-card__actions {
    display: flex;
    gap: 1rem;
    flex-wrap: wrap;
  }

  .article-card__btn {
    display: inline-block;
    padding: 0.6rem 1.5rem;
    font-size: var(--size-sm);
    font-weight: 600;
    text-decoration: none;
    border: 1px solid var(--color-navy);
    color: var(--color-white);
    background-color: var(--color-navy);
    transition: background-color 0.2s, color 0.2s;
  }

  .article-card__btn:hover {
    background-color: var(--color-navy-light);
    border-color: var(--color-navy-light);
  }

  /* Related publications */
  .related-list {
    display: flex;
    flex-direction: column;
    gap: 0;
  }

  .related-item {
    border-left: 2px solid transparent;
    transition: border-color 0.2s;
  }

  .related-item:hover {
    border-left-color: var(--color-accent);
  }

  .related-item a {
    display: block;
    padding: 0.875rem 0 0.875rem 0.75rem;
    text-decoration: none;
    color: inherit;
    border-bottom: 1px solid var(--color-gray-100);
  }

  .related-item:last-child a {
    border-bottom: none;
  }

  .related-item__title {
    display: block;
    font-weight: 600;
    font-size: var(--size-sm);
    color: var(--color-gray-900);
    line-height: 1.5;
    margin-bottom: 0.25rem;
  }

  .related-item a:hover .related-item__title {
    color: var(--color-navy-light);
  }

  .related-item__meta {
    display: block;
    font-size: var(--size-xs);
    color: var(--color-gray-300);
  }

  @media (max-width: 768px) {
    .article-card {
      padding: 1.5rem;
    }
  }
</style>
